Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Dr. Flea's blog
Nurse at small
Your Child's Health Blog
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Friday, January 26, 2007
A non-MD, new Joslin CEO suits tight times, scientists say
Research money isn't what it used to be. Neither is the leadership of the Joslin Diabetes Center.
But Ranch C. Kimball, Joslin's first non-physician president and CEO, won "surprisingly positive" reviews from scientists when he made the rounds at the Harvard affiliate before being named. A memo summarizing the scientists' impressions of Kimball also said he had "obvious intellectual gifts and understood researchers' needs."
Kimball comes from the Romney administration, where he was secretary of economic development. He takes over from Dr. C. Ronald Kahn, who returned to full-time research in September.
"We realize this is probably an unusual choice of a president," said Dr. Steven E. Shoelson, a Joslin researcher and clinician. "I think it relates to the specific demands of the time. With NIH funding going down and more and more competition for research dollars, the board felt a specific need to strengthen our ability to compete for development dollars."
Joslin's outpatient clinic, run jointly with Beth Israel Deaconess Medical Center, loses money because that kind of primary care -- unlike surgery -- isn't reimbursed very well.
Total revenues and expenses both grew a little over 1 percent from fiscal 2004 to 2005. Its surplus was about $4.6 million both years. Philanthropy has averaged about $12 million over the last four years.
One researcher who asked not to be named said he's getting only 80 percent of the money he used to pull in from NIH.